IOVA Operating Cash Flow (Statement)
Iovance Biotherapeutics Inc · Operating Cash Flow (Statement)
IOVA Operating Cash Flow (Statement)
Latest reported-$60.84Mperiod ending
IOVA Quarterly Cash from Operations (-$27.96K → -$60.84M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
IOVA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -60,841,000 | |
| -72,074,000 | |
| -52,565,000 | |
| -78,702,000 | |
| -67,447,000 | |
| -103,694,000 | |
| -73,296,000 | |
| -58,973,000 | |
| -98,429,000 | |
| -122,279,000 | |
| -83,970,000 | |
| -84,083,000 | |
| -93,952,000 | |
| -99,815,000 | |
| -77,671,000 | |
| -63,649,000 | |
| -77,635,000 | |
| -73,802,000 | |
| -53,849,000 | |
| -57,693,000 | |
| -54,008,000 | |
| -62,391,000 | |
| -62,692,000 | |
| -40,515,000 | |
| -36,635,000 | |
| -65,292,000 | |
| -53,822,000 | |
| -42,182,000 | |
| -33,795,000 | |
| -29,090,000 | |
| -31,549,000 | |
| -27,928,000 | |
| -23,923,000 | |
| -17,849,000 | |
| -20,964,000 | |
| -21,446,000 | |
| -17,496,000 | |
| -18,803,000 | |
| -12,159,000 | |
| -12,209,000 | |
| -3,748,000 | |
| -4,552,000 | |
| -6,579,000 | |
| -3,843,421 | |
| -4,499,930 | |
| -3,458,649 | |
| -3,314,930 | |
| -1,728,763 | |
| -1,322,191 | |
| -2,267,363 | |
| -2,253,190 | |
| -427,073 | |
| -681,929 | |
| -300,000 | |
| 6,654,781 | |
| -280,739 | |
| -1,200,511 | |
| -760,217 | |
| -2,709,654 | |
| -1,649,502 | |
| -1,265,568 | |
| -564,475 | |
| -369,592 | |
| -113,320 | |
| -82,274 | |
| -55,619 | |
| -12,161 | |
| -536 | |
| -414 | |
| -1,337 | |
| -13,847 | |
| -988 | |
| -14,510 | |
| -27,958 |